Marilyn E. Morris

9.8k total citations · 2 hit papers
189 papers, 7.8k citations indexed

About

Marilyn E. Morris is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Marilyn E. Morris has authored 189 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Oncology, 73 papers in Molecular Biology and 34 papers in Pharmacology. Recurrent topics in Marilyn E. Morris's work include Drug Transport and Resistance Mechanisms (74 papers), Forensic Toxicology and Drug Analysis (30 papers) and Pharmacogenetics and Drug Metabolism (27 papers). Marilyn E. Morris is often cited by papers focused on Drug Transport and Resistance Mechanisms (74 papers), Forensic Toxicology and Drug Analysis (30 papers) and Pharmacogenetics and Drug Metabolism (27 papers). Marilyn E. Morris collaborates with scholars based in United States, Switzerland and Canada. Marilyn E. Morris's co-authors include Shuzhong Zhang, Young Jin Moon, Melanie A. Felmlee, Xiaodong Wang, Xinning Yang, Vivian Rodriguez‐Cruz, Xiaodong Wang, Guohua An, Yan Ji and Suraj G. Bhansali and has published in prestigious journals such as Analytical Biochemistry, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Marilyn E. Morris

189 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism

2005 692 citations Marilyn E. Morris et al. profile →
Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease

2020 280 citations Melanie A. Felmlee, Robert S. Jones et al. Pharmacological Reviews profile →

Peers

Countries citing papers authored by Marilyn E. Morris

Since Specialization

Citations

This map shows the geographic impact of Marilyn E. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn E. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn E. Morris more than expected).

Fields of papers citing papers by Marilyn E. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn E. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn E. Morris. The network helps show where Marilyn E. Morris may publish in the future.

Co-authorship network of co-authors of Marilyn E. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn E. Morris. A scholar is included among the top collaborators of Marilyn E. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn E. Morris. Marilyn E. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Developing a FIP handbook for implementing competency-based education in pharmacy education 2023 ·Pharmacy Education ·Naoko Arakawa, Marwan Akel, Claire Anderson, (unknown), Rula M. Darwish, Andries S. Koster, (unknown), Marilyn E. Morris	1
2	Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease breakdown → 2020 ·Pharmacological Reviews ·Melanie A. Felmlee, Robert S. Jones, Vivian Rodriguez‐Cruz, Kristin E. Follman, Marilyn E. Morris	280
3	Treatment of γ-Hydroxybutyric Acid and γ-Butyrolactone Overdose with Two Potent Monocarboxylate Transporter 1 Inhibitors, AZD3965 and AR-C155858 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Kristin E. Follman, Marilyn E. Morris	12
4	Pharmacokinetics of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Mice: Potential Enterohepatic Circulation and Target-Mediated Disposition 2019 ·Pharmaceutical Research ·Xiaowen Guan, Marilyn E. Morris	17
5	Mechanistic Modeling of Monocarboxylate Transporter-Mediated Toxicokinetic/Toxicodynamic Interactions Between γ-Hydroxybutyrate and l-Lactate 2014 ·The AAPS Journal ·Bridget L. Morse, (unknown), Marilyn E. Morris	9
6	γ-Hydroxybutyrate (GHB)-Induced Respiratory Depression: Combined Receptor-Transporter Inhibition Therapy for Treatment in GHB Overdose 2012 ·Molecular Pharmacology ·Bridget L. Morse, (unknown), Marilyn E. Morris	38
7	Biliary excretion in dogs: Evidence for a molecular weight threshold 2010 ·European Journal of Pharmaceutical Sciences ·Xinning Yang, Yash Gandhi, Marilyn E. Morris	8
8	Concentration-Effect Relationships for the Drug of Abuse γ-Hydroxybutyric Acid 2010 ·Journal of Pharmacology and Experimental Therapeutics ·Melanie A. Felmlee, Samuel A. Roiko, Bridget L. Morse, Marilyn E. Morris	41
9	Mechanistic Toxicokinetic Model for γ-Hydroxybutyric Acid: Inhibition of Active Renal Reabsorption as a Potential Therapeutic Strategy 2010 ·The AAPS Journal ·Melanie A. Felmlee, Qi Wang, Dapeng Cui, Samuel A. Roiko, Marilyn E. Morris	22
10	ABC transporters and isothiocyanates: potential for pharmacokinetic diet–drug interactions 2009 ·Biopharmaceutics & Drug Disposition ·(unknown), Yan Ji, Marilyn E. Morris	28
11	Prediction of Biliary Excretion in Rats and Humans Using Molecular Weight and Quantitative Structure–Pharmacokinetic Relationships 2009 ·The AAPS Journal ·Xinning Yang, Yash Gandhi, David B. Duignan, Marilyn E. Morris	85
12	Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse γ-Hydroxybutyric Acid 2008 ·The AAPS Journal ·Marilyn E. Morris, Melanie A. Felmlee	159
13	The Role of Monocarboxylate Transporter 2 and 4 in the Transport of γ-Hydroxybutyric Acid in Mammalian Cells 2007 ·Drug Metabolism and Disposition ·Qi Wang, Marilyn E. Morris	45
14	Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein 2005 ·Biochemical Pharmacology ·Shuzhong Zhang, Xinning Yang, Robert A. Coburn, Marilyn E. Morris	155
15	Pharmacokinetics and bioavailability of a newly synthesized dihydropyridine compound with multidrug resistance reversal activity 2005 ·Biopharmaceutics & Drug Disposition ·(unknown), (unknown), Robert A. Coburn, Marilyn E. Morris	1
16	Effects of Benzyl‐, Phenethyl‐, and α‐naphthyl Isothiocyanates on P‐glycoprotein‐ and MRP1‐mediated Transport 2004 ·Journal of Pharmaceutical Sciences ·Ke Hu, Marilyn E. Morris	47
17	Choline Uptake in Human Intestinal Caco-2 Cells Is Carrier-Mediated 2003 ·Journal of Nutrition ·Amrita V. Kamath, (unknown), Marilyn E. Morris	31
18	Hormonal Regulation of Sodium/Sulfate Co-Transport in Renal Epithelial Cells 2000 ·Proceedings of The Society for Experimental Biology and Medicine ·Hwajeong Lee, Kazuko Sagawa, Wei Shi, Heini Murer, Marilyn E. Morris	14
19	Rapid Solubility Determination Using Vapor-Phase Osmometry 1999 ·SLAS DISCOVERY ·(unknown), (unknown), (unknown), Marilyn E. Morris, Murali Ramanathan	4
20	Sulfate homeostasis. I. Effect of salicylic acid and its metabolites on inorganic sulfate in rats. 1988 ·Journal of Pharmacology and Experimental Therapeutics ·Marilyn E. Morris, (unknown), (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact